Cargando…
What Inhibits Natural Killers’ Performance in Tumour
Natural killer cells are innate lymphocytes with the ability to lyse tumour cells depending on the balance of their activating and inhibiting receptors. Growing numbers of clinical trials show promising results of NK cell-based immunotherapies. Unlike T cells, NK cells can lyse tumour cells independ...
Autores principales: | Papak, Ines, Chruściel, Elżbieta, Dziubek, Katarzyna, Kurkowiak, Małgorzata, Urban-Wójciuk, Zuzanna, Marjański, Tomasz, Rzyman, Witold, Marek-Trzonkowska, Natalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266640/ https://www.ncbi.nlm.nih.gov/pubmed/35806034 http://dx.doi.org/10.3390/ijms23137030 |
Ejemplares similares
-
Adoptive Cell Therapy—Harnessing Antigen-Specific T Cells to Target Solid Tumours
por: Chruściel, Elżbieta, et al.
Publicado: (2020) -
The effects of RNA editing in cancer tissue at different stages in carcinogenesis
por: Kurkowiak, Małgorzata, et al.
Publicado: (2021) -
Autoimmunity and Cancer—Two Sides of the Same Coin
por: Sakowska, Justyna, et al.
Publicado: (2022) -
Catamenial pneumothorax – a review of the literature
por: Marjański, Tomasz, et al.
Publicado: (2016) -
A narrative review of invasive diagnostics and treatment of early lung cancer
por: Dziedzic, Robert, et al.
Publicado: (2021)